In 1976, Kostner et al. were the first to describe abnormal LDL particles that occurred in patients with obstructive jaundice and classified them into three subtypes named lipoprotein-X (LP-X), lipoprotein-Y (LP-Y), and lipoprotein-B (LP-B) [34]. Here, PSMB5 is linked to obstructive jaundice.